Chuangmei Pharmaceutical Co., Ltd. (stock code: 2289.HK) is mainly engaged in pharmaceutical distribution business. It mainly distributes Western medicines, proprietary Chinese medicines, health products and other products to downstream distributors and retail terminals. It also provides third-party logistics services and pharmaceutical product consulting services. The company was founded in 2000, and after 23 years of rapid development, it has grown into one of the leading pharmaceutical distributors in South China. Adhering to the development strategy of “deepening Guangdong and radiating the periphery”, the company is based in Shantou, has set up subsidiaries in Guangzhou, Zhuhai, Huizhou, Foshan and Shenzhen, and has four modern pharmaceutical logistics centers, professional marketing service teams and transportation service teams to implement an efficient distribution mechanism of “three parts a day within a radius of 10 kilometers, two parts a day within 50 kilometers, and one distribution per day within 250 kilometers” for the non-tender market. The company has a modern information system covering the entire pharmaceutical distribution supply chain, including procurement, sales, warehousing, transportation and delivery. The company also operates its own B2B e-commerce platform, “Chuangmei e-Medicine”, for customers to place orders, make inquiries and make payments online. The company ranked in the top 40 in the top 100 of the main business revenue of wholesale enterprises in the country in 2021. The company ranked 6th among pharmaceutical distribution companies in Guangdong Province. In 2022, based on its good reputation and quality service, the company received the 2021-2022 Pharmaceutical Cold Chain Logistics Service Recommended Company issued by the Pharmaceutical Chain Ring Platform (obtained for 3 consecutive years) and the 2021-2022 Pharmaceutical Cold Chain Best Logistics Center (base) (obtained for 4 consecutive years); the company received the 2022 Pharmaceutical Logistics Distribution Excellent Enterprise (obtained for 2 consecutive years) from the Pharmaceutical Chain Certification Center and the 2022 Modern Pharmaceutical Logistics Technology Experimental Base (Center); awarded by the China (Guangzhou) International Logistics Equipment and Technology Exhibition Organizing Committee The 2021-2022 China Logistics Industry Golden Ant Innovation Award (received for 5 consecutive years), and received a certificate to participate in the honest development of enterprises in Guangdong Province issued by the Guangdong Federation of Enterprises and the Guangdong Entrepreneurs Association for 11 consecutive years; and received the 2022 China Pharmaceutical Supply Chain Innovation Enterprise issued by the Pharmaceutical Logistics Branch of the China Federation of Logistics and Purchasing.
No Data